Roundkeep Capital's Favorite Stock Picks
Insider Monkey
•
Thu, Jun 23, 2011
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
42 people get CLDA articles and Market Currents by email alert.
Get email alerts on CLDA »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Merger Arbitrage Mondays: April 18, 2011Asif Suria • Mon, Apr 18, 2011 -
-
Russell 2000 at Highest Level Since 2007Value Expectations • Tue, Apr 5, 2011 -
-
-
-
Merger Arbitrage Mondays: March 14, 2011Asif Suria • Mon, Mar 14, 2011
-
-
Merger Arbitrage Mondays: February 28, 2011Asif Suria • Tue, Mar 1, 2011
-
-
-
-
-
-
-
-
Best and Worst Performing Stocks of 2011Bespoke Investment Group • Tue, Feb 1, 2011
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
Bulls Taking a Dose of Clinical DataoptionMONSTER • Thu, Dec 16, 2010 -
-
-
Roundkeep Capital's Favorite Stock PicksInsider Monkey • Thu, Jun 23, 2011
-
-
Merger Arbitrage Mondays: April 18, 2011Asif Suria • Mon, Apr 18, 2011
-
-
Russell 2000 at Highest Level Since 2007Value Expectations • Tue, Apr 5, 2011
-
-
-
-
Merger Arbitrage Mondays: March 14, 2011Asif Suria • Mon, Mar 14, 2011
-
-
Merger Arbitrage Mondays: February 28, 2011Asif Suria • Tue, Mar 1, 2011
-
-
-
-
-
-
-
Best and Worst Performing Stocks of 2011Bespoke Investment Group • Tue, Feb 1, 2011
-
-
Monday Options RecapFrederic Ruffy • Mon, Jan 24, 2011
There are no Transcripts on CLDA.
-
at CNBC.com (Feb 22, 2011)
-
at MarketWatch.com (Feb 22, 2011)
-
at CNBC.com (Feb 22, 2011)
-
at MarketWatch.com (Feb 22, 2011)
-
at CNBC.com (Feb 22, 2011)
-
at CNBC.com (Feb 15, 2011)
-
at MarketWatch.com (Jan 24, 2011)
-
at CNBC.com (Jan 24, 2011)
-
at CNBC.com (Jan 24, 2011)
-
at MarketWatch.com (Jan 24, 2011)
-
at CNBC.com (Jan 24, 2011)
-
at CNBC.com (Dec 13, 2010)
CLDA vs. ETF Alternatives
Company Description
Currently, there's no company description for CLDA.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, February 22, 2011, 8:07 AM Forest Laboratories (FRX) to acquire Clinical Data (CLDA) for $30/share in cash and another $6/share on milestones. The $1.2B deal is a 6.6% premium to the average share price since CLDA announced FDA approval of its major depressive disorder treatment Viibryd, which sent shares up more than 50%. (PR) Comment!
-
Thursday, February 3, 2011, 9:10 AM
Premarket gainers: HNSN +42%. FRG +38%. SFLY +17%. GMCR +17%. BJ +14%. NETL +10%. ENTR +7%. PSTI +5%. CLDA +5%. LTD +5%. JCP +4%. KEM +4%. TTM +4%. BX +4%. APKT +4%. YUM +4%.
Losers: ANW -12%. TZOO -11%. RDN -10%. ISIL -8%. GBG -5%. PCX -5%. GLP -4%. RDS.A -4%. ARR -4%. Comment! - Monday, January 24, 2011, 1:52 PM Eight underperforming stocks with increasing put/call ratios, according to Kapitall: Clinical Data (CLDA), Home Inns & Hotels (HIHM), Supervalu (SVU), Volcom (VLCM), Orbitz (OWW), Ctrip.com (CTRP), Clearwire (CLWR), Taseko Mines (TGB). Contrarians may believe these stocks are set to rally based on a high number of open put positions relative to call positions. Comment!
- Monday, January 24, 2011, 9:24 AM Clinical Data (CLDA) announces that its major depressive disorder treatment Viibryd received approval from the FDA. The biotech company says the drug should be available in U.S. pharmacies in Q2. CLDA +67.3% premarket. (PR) Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.